Literature DB >> 3264543

Infiltrate of syphilitic lesions before and after treatment.

A Tosca1, J Lehou, M Hatjivasiliou, A Varelzidis, J D Stratigos.   

Abstract

An immunohistological study of skin biopsy specimens from patients with early syphilis was undertaken before and after treatment (one day after intramuscular administration of 2.4 MIU benzathine penicillin and eight days later, after a total administration of 3.6 MIU. In chancres from seronegative patients treatment with 3.6 MIU usually resulted in fewer immunocompetent cells in the infiltrate. In lesions of secondary syphilis treatment with 2.4 MIU benzathine penicillin produced a significant decrease in immunocompetent cells. After treatment with 3.6 MIU there was no further decrease. It was worth noticing that even eight to nine days after the initial pretreatment biopsy, when 3.6 MIU had been administered, the overall lymphohistiocytic infiltrate was not substantially diminished. Significantly more suppressor (T8+) cells were found in lesions of primary syphilis than of secondary syphilis, and they showed remarkable exocytosis. Activated local T8+ cells may release immunosuppressive lymphokines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264543      PMCID: PMC1194245          DOI: 10.1136/sti.64.5.289

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  16 in total

1.  Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus.

Authors:  A Moretta; M C Mingari; D Santoli; P Perlmann; L Moretta
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

Review 2.  Why is the infectious stage of syphilis prolonged?

Authors:  D J Wright; A S Grimble
Journal:  Br J Vener Dis       Date:  1974-02

3.  Leucocyte migration and cell-mediated immunity in syphilis.

Authors:  K W Fulford; J Brostoff
Journal:  Br J Vener Dis       Date:  1972-12

4.  [Lymphoblastic transformation test during syphilis].

Authors:  C Janot; M Grandidier; P Pupil; J L Thomas; J Beurey; E de Lavergne
Journal:  Presse Med       Date:  1971-10-16       Impact factor: 1.228

5.  [Immuno-allergic lymphoblastogenesis and Treponena antigen in vitro in syphilis].

Authors:  A Bădănoi; M Gavrilesco; G Nicolau; T Cîrciumaresco
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1969 Jun-Sep

6.  Mycosis fungoides: evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages.

Authors:  A D Tosca; A G Varelzidis; J Economidou; J D Stratigos
Journal:  J Am Acad Dermatol       Date:  1986-08       Impact factor: 11.527

Review 7.  Cell-mediated immunity during syphilis.

Authors:  C S Pavis; J D Folds; J B Baseman
Journal:  Br J Vener Dis       Date:  1978-06

8.  Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests.

Authors:  E From; K Thestrup-Pedersen; H Thulin
Journal:  Br J Vener Dis       Date:  1976-08

9.  In situ identification of mononuclear cells in cutaneous infiltrates in discoid lupus erythematosus, sarcoidosis and secondary syphilis.

Authors:  J R Bjerke; H K Krogh; R Matre
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

10.  Detection of nonspecific resistance to Listeria monocytogenes in rabbits infected with Treponema pallidum.

Authors:  R F Schell; D M Musher
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

View more
  14 in total

Review 1.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen.

Authors:  S T Sadiq; J McSorley; A J Copas; J Bennett; S J Edwards; S Kaye; S Kirk; P French; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-10       Impact factor: 3.519

Review 3.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Lesions of primary and secondary syphilis contain activated cytolytic T cells.

Authors:  W C van Voorhis; L K Barrett; J M Nasio; F A Plummer; S A Lukehart
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 5.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

6.  CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.

Authors:  Brandon T Leader; Charmie Godornes; Wesley C VanVoorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?

Authors:  Georg Stary; Irene Klein; Marie-Charlotte Brüggen; Sabine Kohlhofer; Patrick M Brunner; Daniel Spazierer; Leonhard Müllauer; Peter Petzelbauer; Georg Stingl
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

8.  Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis.

Authors:  Juan C Salazar; Adriana R Cruz; Constance D Pope; Liliana Valderrama; Rodolfo Trujillo; Nancy G Saravia; Justin D Radolf
Journal:  J Infect Dis       Date:  2007-02-05       Impact factor: 5.226

9.  Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins.

Authors:  M V Norgard; B S Riley; J A Richardson; J D Radolf
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Flow cytometric analysis of peripheral blood lymphocyte immunophenotypes in persons infected with Treponema pallidum.

Authors:  V Pope; S A Larsen; R J Rice; S N Goforth; C E Parham; M B Fears
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.